These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34102834)

  • 1. Role of Iron in the Molecular Pathogenesis of Diseases and Therapeutic Opportunities.
    Abbasi U; Abbina S; Gill A; Takuechi LE; Kizhakkedathu JN
    ACS Chem Biol; 2021 Jun; 16(6):945-972. PubMed ID: 34102834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications.
    Liu Q; Sun L; Tan Y; Wang G; Lin X; Cai L
    Curr Med Chem; 2009; 16(1):113-29. PubMed ID: 19149565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron: effect of overload and deficiency.
    Hider RC; Kong X
    Met Ions Life Sci; 2013; 13():229-94. PubMed ID: 24470094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on disordered iron metabolism and iron overload.
    Ward R
    Hematology; 2010 Oct; 15(5):311-7. PubMed ID: 20863426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron mobilization using chelation and phlebotomy.
    Flaten TP; Aaseth J; Andersen O; Kontoghiorghes GJ
    J Trace Elem Med Biol; 2012 Jun; 26(2-3):127-30. PubMed ID: 22565013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron chelating strategies in systemic metal overload, neurodegeneration and cancer.
    Gumienna-Kontecka E; Pyrkosz-Bulska M; Szebesczyk A; Ostrowska M
    Curr Med Chem; 2014; 21(33):3741-67. PubMed ID: 25005181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of cardiac iron overload in transfusion-dependent thalassemia patients.
    Siri-Angkul N; Chattipakorn SC; Chattipakorn N
    Expert Rev Hematol; 2018 Jun; 11(6):471-479. PubMed ID: 29754517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyopathy associated with iron overload: how does iron enter myocytes and what are the implications for pharmacological therapy?
    Wijarnpreecha K; Kumfu S; Chattipakorn SC; Chattipakorn N
    Hemoglobin; 2015; 39(1):9-17. PubMed ID: 25572185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mini-Review: Is iron-mediated cell death (ferroptosis) an identical factor contributing to the pathogenesis of some neurodegenerative diseases?
    Viktorinova A; Durfinova M
    Neurosci Lett; 2021 Feb; 745():135627. PubMed ID: 33440237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of iron metabolism in health and disease.
    Dev S; Babitt JL
    Hemodial Int; 2017 Jun; 21 Suppl 1(Suppl 1):S6-S20. PubMed ID: 28296010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis.
    Sikorska K; Bernat A; Wroblewska A
    Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):461-479. PubMed ID: 27733315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of iron and chelators on infections in iron overload and non iron loaded conditions: prospects for the design of new antimicrobial therapies.
    Kontoghiorghes GJ; Kolnagou A; Skiada A; Petrikkos G
    Hemoglobin; 2010 Jun; 34(3):227-39. PubMed ID: 20524813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of long term iron chelation treatment with deferoxamine.
    Davis BA; Porter JB
    Adv Exp Med Biol; 2002; 509():91-125. PubMed ID: 12572991
    [No Abstract]   [Full Text] [Related]  

  • 14. Prooxidant mechanisms in iron overload cardiomyopathy.
    Cheng CF; Lian WS
    Biomed Res Int; 2013; 2013():740573. PubMed ID: 24350287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ellagic acid isolated from Clerodendrum viscosum leaves ameliorates iron-overload induced hepatotoxicity in Swiss albino mice through inhibition of oxidative stress and the apoptotic pathway.
    Shendge AK; Basu T; Panja S; Chaudhuri D; Mandal N
    Biomed Pharmacother; 2018 Oct; 106():454-465. PubMed ID: 29990833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New advances in iron metabolism, iron deficiency, and iron overload.
    Brittenham GM
    Curr Opin Hematol; 1994 Mar; 1(2):101-6. PubMed ID: 9371267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the understanding of iron metabolism and iron-related diseases.
    Hoffbrand AV
    Acta Haematol; 2009; 122(2-3):75-7. PubMed ID: 19907143
    [No Abstract]   [Full Text] [Related]  

  • 18. Iron and oxidative stress in cardiomyopathy in thalassemia.
    Berdoukas V; Coates TD; Cabantchik ZI
    Free Radic Biol Med; 2015 Nov; 88(Pt A):3-9. PubMed ID: 26216855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canonical Wnt Signaling in the Pathology of Iron Overload-Induced Oxidative Stress and Age-Related Diseases.
    Armstrong A; Mandala A; Malhotra M; Gnana-Prakasam JP
    Oxid Med Cell Longev; 2022; 2022():7163326. PubMed ID: 35116092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular iron overload leading to DNA damage of lymphocytes and immune dysfunction in thalassemia major patients.
    Shaw J; Chakraborty A; Nag A; Chattopadyay A; Dasgupta AK; Bhattacharyya M
    Eur J Haematol; 2017 Nov; 99(5):399-408. PubMed ID: 28815805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.